Pursuant to 35 U.S.C. §287(a), Cardiologs Technologies products are protected by one or more U.S. patents. Each product also may be covered by one or more foreign patents and additional patent application(s) may still be pending.
The following list of products and U.S. patents may not be all inclusive, and other products not listed here may be protected by one or more patents.
|Cardiologs ECG Analysis Platform||US10426364, US10758139, US10779744|
|Cardiologs ECG Analysis Platform||EP Patent No. 3367897 (AT, BE, CH, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LT, LU, LV, NL, NO, PL, PT, RO, SE, TR)|
The ECG Holter agreement marks the launch of Cardiologs’ AI-based cloud technology business operations in Europe to detect cardiac rhythm disorders. BOSTON, Sept. 1, 2020 /PRNewswire/ — Cardiologs, a global…READ FULL
Data presented at HRS 2020 shows Cardiologs’ AI-system successfully eliminates more than two-thirds of atrial fibrillation false positives from ILR reports, alleviating the clinical burden associated with remote monitoring PARIS…READ FULL
Trial will evaluate use of Cardiologs’ AI platform for QT interval analysis of ECG data from smartwatches in patients receiving hydroxychloroquine treatment BOSTON, April 22, 2020 /PRNewswire/ — Cardiologs, a…READ FULL
Funding will accelerate adoption of the company’s breakthrough AI-based heart disease diagnostic solution by supporting physicians with unprecedented EKG data analysis and reporting capabilities PARIS and BOSTON, Jan. 10, 2020 /PRNewswire/ — Cardiologs, a global leader…READ FULL
Cloud-based AI Technology Recognized for Providing Faster, More Accurate EKG Analysis PARIS and BOSTON, Dec. 9, 2019 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, announced…READ FULL
Cloud-based AI Solution for EKG Analysis Recognized in “Best Technological Innovation: Digital” Category PARIS and BOSTON, Aug. 29, 2019 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology…READ FULL